Live feed
Filing
SC 13G
SC 13G0001019056-17-000090·Abir Therapeutics Ltd
Schedule 13G ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: 2017-01-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,200,000
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-17-000090
- Form type
- SC 13G
- Filer
- Abir Therapeutics Ltd
- CIK
- CIK 1696884
- Filed
- Feb 01, 2017
- Reporting period
- Jan 26, 2017
- Description
- Schedule 13G beneficial ownership